| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |